- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Resectable MMR-deficient Solid Tumors in Belgium
Total 222 results
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Norway, United Kingdom, Switzerland, Netherlands, Belgium, Austria, Denmark, Germany
-
AstraZenecaCompletedSolid TumoursBelgium, France, Netherlands, United Kingdom, Denmark
-
Evangelisches Krankenhaus DüsseldorfOlympusCompletedCrohn's Disease | Gastrointestinal Hemorrhage | Disorder of Small Intestine | Iron Deficiency Anaemia | Small Bowel Tumors | Intestinal Polyposis Syndrome | Coeliac DiseaseBelgium, Germany
-
The Belgian Society of Medical OncologyIllumina, Inc.; OncoDNA; PierianDxRecruiting
-
Novartis PharmaceuticalsTerminatedPhase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid LeukemiaAML | cKIT-positive Solid TumorsBelgium, Spain, Australia, Netherlands
-
Incyte CorporationRecruitingSolid TumorsUnited States, France, Italy, Australia, Spain, Belgium, Canada
-
Gilead SciencesActive, not recruitingMetastatic Solid TumorUnited States, Spain, France, Hong Kong, Australia, Belgium, Taiwan, Canada
-
European Organisation for Research and Treatment...SuspendedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
European Organisation for Research and Treatment...WithdrawnUnspecified Adult Solid Tumor, Protocol SpecificFrance, Norway, Switzerland, Netherlands, Belgium, Austria, United Kingdom, Denmark, Germany
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States, Belgium, Spain, France, United Kingdom, Canada, Denmark
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
Oxford BioTherapeutics LtdRecruitingSolid TumorUnited States, Belgium, Spain, France, Greece
-
BayerCompletedSolid Tumors Harboring NTRK FusionUnited States, Belgium, Italy, Germany, Australia, Spain, Singapore, Denmark, France, Ireland
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey
-
Turning Point Therapeutics, Inc.Zai Lab (Shanghai) Co., Ltd.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, China, Japan, Australia, Belgium, Canada, Denmark, France, Germany, Hong Kong, Hungary, Italy, Korea, Democratic People's Republic of, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Taiwan, United Kingdom
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Taiwan, China, Korea, Republic of, Poland, Italy, Spain, Australia, Brazil, Argentina
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Spain, Denmark, Netherlands, Norway, Belgium, United Kingdom, Israel, Italy, Switzerland, Germany, Austria, Greece, Portugal
-
Novartis PharmaceuticalsCompletedAdvanced and Selected Solid TumorsBelgium, Spain, Canada, Switzerland, United States
-
BayerRecruitingAdvanced Solid TumorsUnited States, Canada, Belgium, Singapore, China, Spain, United Kingdom
-
Epizyme, Inc.Sponsor GmbHRecruitingHepatic Impairment | Advanced Malignant Solid TumorFrance, Belgium, United States, Poland, Slovakia
-
OSE ImmunotherapeuticsRecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | Solid Advanced TumorFrance, Belgium
-
CephalonCompletedSolid Tumors or Mantle Cell LymphomaBelgium, France
-
BayerBristol Myers Squibb Co. and Ono Pharmaceutical Co., LtdActive, not recruitingSolid TumorsUnited States, United Kingdom, Belgium, France, Taiwan, Japan, Italy, Korea, Republic of
-
Nouscom SRLMerck Sharp & Dohme LLCRecruitingSolid Tumor, AdultUnited States, Spain, Italy, Canada, Belgium, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorsUnited States, Chile, Argentina, Belgium, Canada, Japan, Netherlands
-
Astellas Pharma IncCompletedAny Solid Tumor or LymphomaUnited States, Belgium, United Kingdom
-
Bristol-Myers SquibbRecruitingAdvanced Solid TumorsSpain, United States, Netherlands, France, Italy, Belgium
-
Merck KGaA, Darmstadt, GermanyCompletedChronic Lymphocytic Leukemia | Advanced Solid TumorsBelgium, Netherlands, Denmark
-
AmgenRecruitingAdvanced MTAP-null Solid TumorsUnited States, Canada, Taiwan, Switzerland, United Kingdom, Korea, Republic of, Germany, Austria, France, Belgium, Australia, Hong Kong, Japan
-
European Organisation for Research and Treatment...CompletedTesticular Germ Cell Tumor | Unspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Mesothelioma | Advanced Solid Tumor | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | HepatoCellular Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1)France, United States, Japan, Belgium, Australia
-
Blueprint Medicines CorporationCompletedGastrointestinal Stromal Tumors (GIST) | Other Relapsed or Refractory Solid TumorsUnited States, United Kingdom, France, Korea, Republic of, Belgium, Germany, Italy, Netherlands, Poland, Spain
-
Bristol-Myers SquibbCompletedUnresectable or Metastatic MelanomaUnited States, Germany, Italy, United Kingdom, Canada, Denmark, Netherlands, Spain, Belgium, France, Switzerland, Israel, Austria, Brazil
-
Universitair Ziekenhuis BrusselRecruitingSolid Tumor | Non Small Cell Lung CancerBelgium
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedLymphoma | Refractory or Relapsed Solid TumorsKorea, Republic of, United States, Canada, Belgium, Denmark
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Spain, Denmark, Netherlands, Norway, Belgium, United Kingdom, Israel, Italy, Switzerland, Germany, Portugal, Greece, Austria
-
Merus N.V.Incyte CorporationRecruitingAdvanced Cancer | Solid Tumor, Adult | B-cell Lymphoma, AdultUnited States, Spain, Belgium, Netherlands
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
Mural Oncology, IncCompletedAdvanced Solid TumorsCanada, Spain, United States, Australia, Belgium, Korea, Republic of, Poland
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, Canada, France, Taiwan, Belgium, Spain, Singapore, Italy, Australia, Hong Kong, Germany, Japan
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Epizyme, Inc.CompletedSynovial Sarcoma | Epithelioid Sarcoma | Renal Medullary Carcinoma | Malignant Rhabdoid Tumors (MRT) | Rhabdoid Tumors of the Kidney (RTK) | Atypical Teratoid Rhabdoid Tumors (ATRT) | Selected Tumors With Rhabdoid Features | INI1-negative Tumors | Malignant Rhabdoid Tumor of Ovary | Poorly Differentiated... and other conditionsFrance, United States, Australia, Taiwan, Belgium, United Kingdom, Canada, Germany, Italy
-
Menarini GroupTerminatedMetastatic Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaItaly, Spain, Belgium, United Kingdom
-
Novartis PharmaceuticalsTerminatedIn Escalation: All Patients With Solid Tumors and Lymphoma | In Expansion: Melanoma, Non-small Cell Lung CancerUnited States, Italy, Taiwan, Belgium, Spain, Germany, Japan
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
AstraZenecaParexel; Iqvia Pty Ltd; Medidata Solutions; CISCRPActive, not recruitingSolid TumorSpain, United Kingdom, United States, Canada, Czechia, Poland, Romania, Thailand, Vietnam, Belgium, France, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Malaysia, Taiwan, Australia, Germany, Turkey, Ukraine, Nethe... and more